Democratizing hedge fund level analysis tools for everyone
About |
---|
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia and internationally. It operates in three segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing Services. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.. |
Info | Profile |
---|---|
Name | Darya-Varia Laboratoria Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 12/31/2024 |
Name | Latest % | A Month Ago % |
---|---|---|
Blue Sphere Singapore PT. Ltd | 92.12 | 92.12 |
Public < 5% | 7.88 | 7.88 |
Others | 0.01 | 0.0 |
Classification | Latest % | Previous % |
---|---|---|
Institution | 92.12 | 92.12 |
Retail | 7.88 | 7.88 |
Individual | 0.0 | 0.0 |
Management | 0.0 | 0.0 |
Revenue Source | 2023 | 2022 |
---|---|---|
Consumer Health Products | 50.9% | 55.2% |
Prescription Drugs | 37.5% | 33.3% |
Export & Toll | 10.2% | 11.5% |
Services | 1.4% | 0.0% |
Others | 0.0% | 0.0% |
Revenue Region | 2023 | 2022 |
---|---|---|
Indonesia | 90.8% | 89.4% |
International | 9.2% | 10.6% |
Others | 0.0% | 0.0% |
Year | DPS | Yield [%] |
---|---|---|
2024 | 108.0 | 7.6 |
2023 | 121.0 | 7.3 |
Stock | DVLA | DVLA |
Timeframe | Performance |
---|---|
1W % | 5.2 |
1Mo % | -0.7 |
3Mo % | -5.6 |
1Yr % | 7.8 |
Pivot | Points |
---|---|
R2 | 1610 |
R1 | 1520 |
S1 | 1335 |
S2 | 1240 |
Link download Laporan Keuangan emiten
Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
DVLA | 10.60 | 1.59 T | 1.94 T | 2.09 T | 243 B | 156 B |
KLBF | 17.37 | 55.31 T | 55.45 T | 32,600 B | 5,070 B | 3,240 B |
SIDO | 14.09 | 16.65 T | 16.25 T | 3,920 B | 1,580 B | 1,170 B |
TSPC | 8.02 | 10.82 T | 9.70 T | 13,700 B | 2,110 B | 1,450 B |
SOHO | 19.76 | 7.93 T | 10.21 T | 10,100 B | 618 B | 463 B |
KAEF | -4.16 | 2.20 T | 12.80 T | 10,500 B | -9 B | -562 B |